Report on Preventable Vaccines Market Global Key Vendors ,Trend, Analysis, Segmentation, Growth and Forecast to 2019

Preventable Vaccines 

Scope of the Report:

  • About this Report

Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from birth to 18 years of age.

  • Analysis of this report

TechNavio’s analysts forecast the Global Preventable Vaccines market to grow at a CAGR of 10.16 percent over the period 2014-2019..

  • Covered in this Report
    This report covers the present scenario and the growth prospects of the Global Preventable Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of preventable vaccines. The report examines the market for vaccines used in humans. It covers only commercialized vaccines for diseases that are vaccine preventable

The report does not cover emerging vaccines for diseases that are not currently vaccine preventable, such as Ebola infection, Epstein-Ban virus infection, Alzheimer’s disease, diabetes, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, or West Nile virus infection.

The report has broadly categorized preventable vaccines into two major segments:
• Adult Preventable Vaccines
• Pediatric Preventable Vaccines

TechNavio’s report, the Global Preventable Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Preventable Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.


Request For Sample Report
• Key Regions
• Americas

Key Vendors
• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Sanofi

Other Prominent Vendors
• Abbott
• AstraZeneca
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Bharat Immunologicals and Biologicals
• bioCSL
• Bio Med
• Crucell
• Dynavax Technologies
• Indian Immunologicals
• Janssen Pharmaceuticals
• Kaketsuken
• LG Life Sciences
• Mitsubishi Tanabe Pharma
• Lupin
• Nuron
• Protein Sciences
• Panacea Biotec
• Roche
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Serum Institute of India
• Sinovac Biotech
• S K Chemicals
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• Zydus Cadila

Market Driver
• Inclusion in NIP
• For a full, detailed list, view our report

Market Challenge
• Inadequate Vaccine Coverage
• For a full, detailed list, view our report

Market Trend
• Increase in Strategic Alliances
• For a full, detailed list, view our report

Key Questions Answered in this Report 
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 Complete Report

 List of Abbreviations 

  1. Executive Summary
    02. List of Abbreviations
    03. Scope of the Report 

    03.1 Market Overview
    03.2 Product Offerings
    04. Market Research Methodology
    04.1 Market Research Process
    04.2 Research Methodology
    05. Introduction
    06. Vaccine Approval Process
    07. Market Landscape
    07.1 Market Overview
    07.2 Market Size and Forecast
    07.3 Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019
    07.4 Five Forces Analysis
    08. Market Segmentation by Type of Vaccine
    08.1 Live Attenuated Vaccine
    08.2 Killed Vaccine
    08.3 Toxoid Vaccine
    08.4 Genetically Modified/Engineered Vaccine
    09. Market Segmentation by Product Type
        09.1 Polysaccharide Vaccines
    09.2 Conjugate Vaccines
    10. Geographical Segmentation
    11. Global Preventable Vaccines Market by Key Geographies
        11.1 Market Size and Forecast for the US
    11.2 Market Size and Forecast for the EU
    11.3 Market Size and Forecast for Japan
    11.4 Market Size and Forecast for India
    11.5 Market Size and Forecast for China
    12. Global Pediatric Preventable Vaccines Market
    12.1 Global Pediatric Preventable Vaccine Market
    12.1.1 Market Size and Forecast
    12.2 Market Segmentation of the Global Pediatric Preventable Vaccine Market
    12.3 Global Pediatric Hepatitis Vaccines Market
    12.3.1 Market Size and Forecast
    12.4 Global Pediatric Haemophilus Influenzae Type B (Hib) Vaccines Market
    12.4.1 Market Size and Forecast
    12.5 Global Pediatric MMR Vaccines Market
    Market Size and Forecast
    12.6 Global Pediatric Combination Vaccines Market
    12.6.1 Market Size and Forecast
    12.7 Global Pediatric Pneumococcal Vaccines Market
    12.7.1 Market Size and Forecast
    12.8 Global Polio Vaccines Market
    12.8.1 Market Size and Forecast
    12.9 Global Pediatric Varicella Vaccines Market
    12.9.1 Market Size and Forecast
    12.10 Global Other Pediatric Vaccines Market
    12.10.1 Market Size and Forecast
    12.11 Global Pediatric Preventable Vaccines Market 2014 and 2019 (by percentage)
    13. Global Adult Preventable Vaccines Market
    13.1 Market Size and Forecast
    13.2 Market Segmentation of the Global Adult Preventable Vaccines Market
    13.3 Global Adult Cervical Vaccines Market
    13.3.1 Market Size and Forecast
    13.4 Global Adult Hepatitis Vaccines Market
    13.4.1 Market Size and Forecast
    13.5 Global Adult Influenza Vaccines Market
    13.5.1 Market Size and Forecast
    13.6 Global Adult Pneumococcal Vaccines Market
    13.6.1 Market Size and Forecast
    13.7 Global Adult Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market
    13.7.1 Market Size and Forecast
    14. Key Leading Countries
    14.1 US
    14.2 China
    14.3 Japan
    14.4 India
    15. Buying Criteria
    16. Market Growth Drivers
    17. Drivers and their Impact
    18. Market Challenges
    19. Impact of Drivers and Challenges
    20. Market Trends
    21. Trends and their Impact
    22. Vendor Landscape
        22.1 Competitive Scenario
    22.1.1 Key News
    22.1.2 Mergers and Acquisitions
    22.2 Market Share Analysis 2014
    22.2.1 GlaxoSmithKline
    22.2.2 Merck
    22.2.3 Novartis
    22.2.4 Pfizer
    22.2.5 Sanofi
    22.3 Other Prominent Vendors
    23. Key Vendor Analysis 
    23.1 GlaxoSmithKline
    23.1.1 Key Facts
    23.1.2 Business Overview
    23.1.3 Business Segmentation
    23.1.4 Business Segmentation by Revenue 2012 and 2013
    23.1.5 Sales by Geography
    23.1.6 Pipeline Products
    23.1.7 Business Strategy
    23.1.8 Key Information
    23.1.9 SWOT Analysis
        23.2 Merck
    23.2.1 Key Facts
    23.2.2 Business Overview
    23.2.3 Business Segmentation by Revenue 2013
    23.2.4 Business Segmentation by Revenue 2012 and 2013
    23.2.5 Sales by Geography
    23.2.6 Business Strategy
    23.2.7 Key Developments
    23.2.8 SWOT Analysis
    23.3 Novartis
    23.3.1 Key Facts
    23.3.2 Business Description
    23.3.3 Business Segmentation
    23.3.4 Revenue by Business Segmentation
    23.3.5 Revenue Comparison 2012 and 2013
    23.3.6 Sales by Geography
    23.3.7 Business Strategy
    23.3.8 Key Developments
    23.3.9 SWOT Analysis
    23.4 Pfizer
    23.4.1 Key Facts
    23.4.2 Business Overview
    23.4.3 Business Segmentation by Revenue 2013
    23.4.4 Business Segmentation by Revenue 2012 and 2013
    23.4.5 Geographical Segmentation by Revenue
    23.4.6 Business Strategy
    23.4.7 Key Developments
    23.4.8 SWOT Analysis
    23.5 Sanofi
    23.5.1 Key Facts
    23.5.2 Business Description
    23.5.3 Business Segmentation
    23.5.4 Revenue by Business Segmentation
    23.5.5 Revenue Comparison 2012 and 2013
    23.5.6 Sales by Geography
    23.5.7 Business Strategy
    23.5.8 Key Developments
    23.5.9 SWOT Analysis
    24. Other Reports in this Series


Visit to our official website on Linkedin@

Buy This Report@



Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)



Author: Press Release

Publish your press release instantly without any paywall.

Share This Post On


  1. health advice - health advice Piece of writing writing is also a excitement, if you know afterward you can write otherwise it…
  2. free finance advice - free finance advice Hello! I just would like to offer you a big thumbs up for your great information…
  3. investment - investment What's up friends, its fantastic piece of writing regarding educationand completely defined, keep it up all the time.
  4. home internet business - home internet business Hello there, You have done an excellent job. I will definitely digg it and personally suggest…

Leave a Reply